![Mark Lanasa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lanasa
Corporate Officer/Principal presso
BEIGENE LTD
Profilo
Mark Lanasa currently works at BeOne Medicines Ltd., as Chief Medical Officer-Solid Tumors & SVP from 2022.
Mr. Lanasa also formerly worked at AstraZeneca PLC, as Vice President & Head-Enhertu Global Clinical from 2019 to 2022.
Mr. Lanasa received his undergraduate degree from The Pennsylvania State University and graduate degree and doctorate degree from the University of Pittsburgh School of Medicine.
Posizioni attive di Mark Lanasa
| Società | Posizione | Inizio |
|---|---|---|
| BEIGENE LTD | Corporate Officer/Principal | 09/02/2022 |
Precedenti posizioni note di Mark Lanasa
| Società | Posizione | Fine |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2022 |
Formazione di Mark Lanasa
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
